JP2022517797A5 - - Google Patents
Info
- Publication number
- JP2022517797A5 JP2022517797A5 JP2021541215A JP2021541215A JP2022517797A5 JP 2022517797 A5 JP2022517797 A5 JP 2022517797A5 JP 2021541215 A JP2021541215 A JP 2021541215A JP 2021541215 A JP2021541215 A JP 2021541215A JP 2022517797 A5 JP2022517797 A5 JP 2022517797A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962793623P | 2019-01-17 | 2019-01-17 | |
| US62/793,623 | 2019-01-17 | ||
| US201962861702P | 2019-06-14 | 2019-06-14 | |
| US62/861,702 | 2019-06-14 | ||
| PCT/US2020/013824 WO2020150439A1 (en) | 2019-01-17 | 2020-01-16 | Compounds and compositions for treating conditions associated with sting activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022517797A JP2022517797A (ja) | 2022-03-10 |
| JP2022517797A5 true JP2022517797A5 (https=) | 2023-01-20 |
| JPWO2020150439A5 JPWO2020150439A5 (https=) | 2023-01-20 |
Family
ID=69593778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021541215A Pending JP2022517797A (ja) | 2019-01-17 | 2020-01-16 | Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220388957A1 (https=) |
| EP (1) | EP3911314A1 (https=) |
| JP (1) | JP2022517797A (https=) |
| CN (1) | CN113874010A (https=) |
| MA (1) | MA54753A (https=) |
| WO (1) | WO2020150439A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112823036B (zh) | 2018-07-03 | 2024-11-08 | 艾福姆德尤股份有限公司 | 用于治疗与sting活性有关的疾病的化合物和组合物 |
| CN112375027B (zh) * | 2020-12-07 | 2023-03-31 | 中国药科大学 | 吲哚磺酰胺类衍生物及其医药用途 |
| US20240060982A1 (en) | 2020-12-22 | 2024-02-22 | Ifm Due, Inc. | Methods of treating cancer |
| WO2022140397A1 (en) | 2020-12-22 | 2022-06-30 | Ifm Due, Inc. | Methods of treating cancer |
| EP4267128A1 (en) | 2020-12-22 | 2023-11-01 | IFM Due, Inc. | Methods of treating cancer |
| EP4267129A1 (en) | 2020-12-22 | 2023-11-01 | IFM Due, Inc. | Methods of treating cancer |
| TW202235073A (zh) | 2021-01-08 | 2022-09-16 | 美商Ｉｆｍ Ｄｕｅ有限公司 | 用於治療與sting活性相關的病狀之化合物及組合物 |
| UY39892A (es) | 2021-08-10 | 2023-03-31 | Novartis Pharma Ag | Compuestos y composiciones para tratar afecciones asociadas con la actividad de STING |
| KR20250052376A (ko) * | 2022-08-26 | 2025-04-18 | 에프. 호프만-라 로슈 아게 | 신규 중수소화 피리미딘-2-일 설폰아미드 유도체 |
| WO2024064358A1 (en) | 2022-09-23 | 2024-03-28 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0511993A1 (en) * | 1990-01-22 | 1992-11-11 | E.I. Du Pont De Nemours And Company | Herbicidal sulfonylureas |
| US6521658B1 (en) * | 1999-05-28 | 2003-02-18 | Abbott Laboratories | Cell proliferation inhibitors |
| AU2002306604B2 (en) * | 2001-02-28 | 2007-09-13 | Onconova Therapeutics, Inc. | N-(Aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| CA2473803A1 (en) * | 2002-02-01 | 2003-08-07 | Robert Greenhouse | Substituted indoles as alpha-1 agonists |
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| US7390670B2 (en) * | 2003-02-20 | 2008-06-24 | Lumigen, Inc. | Signalling compounds and methods for detecting hydrogen peroxide |
| DK2142516T3 (da) * | 2007-03-30 | 2013-04-15 | Sanofi Sa | Pyrimidinhydrazidforbindelser i ders egenskab af pgds-inhibitorer |
| WO2012075380A1 (en) | 2010-12-03 | 2012-06-07 | The Trustees Of The University Of Pennsylvania | Tip60 inhibitors |
| CN109394752A (zh) | 2013-10-21 | 2019-03-01 | 德雷克塞尔大学 | 治疗慢性乙型肝炎病毒感染的sting激动剂的用途 |
| FR3017867A1 (fr) * | 2014-02-21 | 2015-08-28 | Inventiva | Nouveaux composes de type phenylazetidine carboxylate ou carboxamide |
| AR106018A1 (es) * | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
| WO2017153952A1 (en) * | 2016-03-10 | 2017-09-14 | Glaxosmithkline Intellectual Property Development Limited | 5-sulfamoyl-2-hydroxybenzamide derivatives |
| US10858344B2 (en) * | 2016-11-23 | 2020-12-08 | Cv6 Therapeutics (Ni) Limited | Hydantoin containing deoxyuridine triphosphatase inhibitors |
| TWI754702B (zh) * | 2016-12-28 | 2022-02-11 | 德商Ｕｃｂ製藥有限公司 | （氮雜）吲哚－和苯並呋喃－３－磺醯胺類 |
| CN112823036B (zh) * | 2018-07-03 | 2024-11-08 | 艾福姆德尤股份有限公司 | 用于治疗与sting活性有关的疾病的化合物和组合物 |
| US20210236466A1 (en) * | 2018-07-03 | 2021-08-05 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| EP3883651A1 (en) * | 2018-11-19 | 2021-09-29 | IFM Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| US20230092163A1 (en) * | 2019-06-14 | 2023-03-23 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| EP3983384B1 (en) * | 2019-06-17 | 2023-10-11 | UCB Pharma GmbH | N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as gpr17 modulators for treating cns disorders such as multiple sclerosis |
| CN114761804A (zh) * | 2019-06-21 | 2022-07-15 | 艾福姆德尤股份有限公司 | 治疗癌症的方法 |
-
2020
- 2020-01-16 MA MA054753A patent/MA54753A/fr unknown
- 2020-01-16 JP JP2021541215A patent/JP2022517797A/ja active Pending
- 2020-01-16 US US17/422,397 patent/US20220388957A1/en not_active Abandoned
- 2020-01-16 EP EP20705838.9A patent/EP3911314A1/en not_active Withdrawn
- 2020-01-16 CN CN202080021980.7A patent/CN113874010A/zh active Pending
- 2020-01-16 WO PCT/US2020/013824 patent/WO2020150439A1/en not_active Ceased